AzTrials
AzTrials

Lumbar Disc HerniationNCT07166250

Comparison of the Effects of Quadratus Lumborum Block and Retrolaminar Block on Postoperative Pain in Lumbar Disc Herniation Surgery

A study testing Quadratus Lumborum Block and Retrolaminar Block in people with Lumbar Disc Herniation and Postoperative Pain, run by Kocaeli University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to compare the analgesic efficacy of quadratus lumborum block (QLB) and retrolaminar block (RLB) in patients undergoing lumbar disc herniation surgery. Both regional anesthesia techniques are increasingly used for postoperative pain management, but there is limited evidence directly comparing their… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Lumbar Disc Herniation, Postoperative Pain
What is being tested?
Quadratus Lumborum Block and Retrolaminar Block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
82 participants
Where
1 siteTurkey (Türkiye)
Study dates
16 May 2024to 20 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged 18-65 years
  • American Society of Anesthesiologists (ASA) physical status I-II-III
  • Scheduled for elective lumbar disc herniation surgery under general anesthesia
  • Willing to participate and provide written informed consent
  • Patients scheduled for elective lumbar disc herniation surgery

Who cannot join

  • Patients requiring emergency surgery
  • ASA physical status classification IV-V
  • Known coagulopathy
  • Ongoing anticoagulant therapy
  • History of allergy to local anesthetics
  • Localized infection at the block injection site
Show all 9Show fewer
  • Presence of spinal, paraspinal, or regional deformities at the block area
  • Inability to understand or use the verbal pain rating scale
  • Chronic use of analgesic medications

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Kocaeli University Hospital

    Kocaeli, 41000

Other trials in Turkey (Türkiye)

About this study

This study aims to compare the analgesic efficacy of quadratus lumborum block (QLB) and retrolaminar block (RLB) in patients undergoing lumbar disc herniation surgery. Both regional anesthesia techniques are increasingly used for postoperative pain management, but there is limited evidence directly comparing their effectiveness. The primary outcome is postoperative opioid consumption, while secondary outcomes include postoperative pain scores

Read the detailed description

Effective postoperative pain management is essential in patients undergoing lumbar disc herniation surgery. Regional anesthesia techniques, such as quadratus lumborum block (QLB) and retrolaminar block (RLB), have been increasingly used as alternatives or adjuncts to systemic analgesics. QLB provides analgesia by targeting the thoracolumbar fascia and spreading to the paravertebral space, whereas RLB is considered a simpler and potentially safer approach with similar analgesic potential.

This randomized controlled clinical trial is designed to compare the efficacy and safety of QLB and RLB for postoperative pain control. Adult patients scheduled for elective lumbar disc herniation surgery under general anesthesia will be randomized into two groups. One group will receive ultrasound-guided QLB, and the other group will receive ultrasound-guided RLB before surgical incision.

The primary outcome is total postoperative morphine consumption during the first 24 hours after surgery. Secondary outcomes include postoperative pain intensity measured using the Numerical Rating Scale (NRS) at multiple time points within the first 24 hours, the need for rescue analgesia, postoperative nausea and vomiting (PONV), and block-related complications.

Being tested
Quadratus Lumborum Block, Retrolaminar Block
Keywords
Quadratus Lumborum Block, Retrolaminar Block, Spine Surgery Analgesia, Opioid Consumption
Medical subject headings
Intervertebral Disc Displacement, Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quadratus Lumborum BlockProcedure or surgery

    Ultrasound-guided quadratus lumborum block performed preoperatively using local anesthetic injection at the thoracolumbar fascia for postoperative analgesia in lumbar disc herniation surgery.

  • Retrolaminar BlockProcedure or surgery

    Ultrasound-guided retrolaminar block performed preoperatively using local anesthetic injection into the retrolaminar space for postoperative analgesia in lumbar disc herniation surgery

Study groups in NCT07166250
Study groupRoleWhat they receive
Quadratus Lumborum BlockExperimentalPatients randomized to this group will receive an ultrasound-guided quadratus lumborum block (QLB) with local anesthetic injection before surgical incision for postoperative pain management.
Receives: Procedure: Quadratus Lumborum Block
Retrolaminar BlockExperimentalPatients randomized to this group will receive an ultrasound-guided retrolaminar block (RLB) with local anesthetic injection before surgical incision for postoperative pain management.
Receives: Procedure: Retrolaminar Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total Postoperative Opioid Consumption

    Total cumulative amount of intravenous morphine consumed (in milligrams) via patient-controlled analgesia (PCA) device.

    Measured: Within the first 24 hours after surgery

Secondary outcomes (2)
  1. Postoperative pain intensity (Numerical Rating Scale, NRS 0-10)

    Pain intensity will be assessed using the Numerical Rating Scale (NRS), where 0 = no pain and 10 = worst imaginable pain.

    Measured: Within the first 24 hours after surgery

  2. Need for rescue analgesia

    Number of patients requiring additional rescue analgesic medication during the postoperative period.

    Measured: Within the first 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2025
  2. Study start16 May 2024
  3. Primary completion26 Dec 2025
  4. Study completion20 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two-arm randomized controlled trial comparing quadratus lumborum block and retrolaminar block in patients undergoing lumbar disc herniation surgery.
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
82 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07166250
Sponsor's protocol ID
KANDEMIR-QLB-O
Status last verified
Oct 2026
First submitted
3 Sep 2025
Last updated
22 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Quadratus Lumborum Block and Retrolaminar Block in people with Lumbar Disc Herniation and Postoperative Pain, run by Kocaeli University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total Postoperative Opioid Consumption (time frame: Within the first 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in